NASDAQ:NKTR

Nektar Therapeutics Stock Insider Trading

etoro logo Buy NKTR
*Your capital is at risk
$59.23
+0.670 (+1.14%)
At Close: Jun 03, 2026

Nektar Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -15.77. In total, the insiders bought 1.7M and sold 304.05K NKTR shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-15.77
Buy 1.7M shares
Sell 304.05K shares
37% Buy Activity
Negligible or No Correlation
Sell Signal Low Confidence
May 19, 2026

Analysis Breakdown:

  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
May 19, 2026
Sell
Common Stock
S-Sale
Zalevsky Jonathan
Chief R&d Officer
Officer 199
Value: $13.0K
May 19, 2026
Sell
Common Stock
S-Sale
Robin Howard W
President & CEO
CEO / President 444
Value: $29.1K
May 15, 2026
Buy
Common Stock
J-Other
Rubinstein Linda M
Insider
Other 0
Value: $0
Feb 18, 2026
Sell
Common Stock
S-Sale
Robin Howard W
President & CEO
CEO / President 423
Value: $30.9K
Feb 18, 2026
Sell
Common Stock
S-Sale
Zalevsky Jonathan
Chief R&d Officer
Officer 180
Value: $13.1K
Jan 20, 2026
Sell
Common Stock
S-Sale
Zalevsky Jonathan
Chief R&d Officer
Officer 3 867
Value: $137.9K
Dec 22, 2025
Buy
Common Stock
A-Award
Robin Howard W
President & CEO
CEO / President 21 667
Value: $942.1K
Dec 22, 2025
Buy
Stock Option
A-Award
Robin Howard W
President & CEO
CEO / President 86 667
Value: $3.77M
Dec 22, 2025
Buy
Stock Option
A-Award
Zalevsky Jonathan
Chief R&d Officer
Officer 25 000
Value: $1.09M
Dec 22, 2025
Buy
Common Stock
A-Award
Zalevsky Jonathan
Chief R&d Officer
Officer 6 250
Value: $271.8K
Nov 25, 2025
Sell
Common Stock
S-Sale
Robin Howard W
President & CEO
CEO / President 2 207
Value: $119.8K
Nov 25, 2025
Sell
Common Stock
S-Sale
Wilson Mark Andrew
Chief Legal Officer
Officer 630
Value: $34.2K
Nov 25, 2025
Sell
Common Stock
S-Sale
Zalevsky Jonathan
Chief R&d Officer
Officer 1 157
Value: $62.8K
Nov 21, 2025
Buy
Stock Option
A-Award
Robin Howard W
President & CEO
CEO / President 12 170
Value: $3.42M
Nov 21, 2025
Buy
Common Stock
A-Award
Robin Howard W
President & CEO
CEO / President 7 110
Value: $385.9K
Nov 21, 2025
Buy
Stock Option
A-Award
Wilson Mark Andrew
Chief Legal Officer
Officer 3 400
Value: $956.3K
Nov 21, 2025
Buy
Common Stock
A-Award
Zalevsky Jonathan
Chief R&d Officer
Officer 2 666
Value: $144.7K
Nov 21, 2025
Buy
Stock Option
A-Award
Zalevsky Jonathan
Chief R&d Officer
Officer 4 766
Value: $1.34M
Nov 21, 2025
Buy
Common Stock
A-Award
Wilson Mark Andrew
Chief Legal Officer
Officer 1 903
Value: $103.3K
Sep 30, 2025
Buy
Stock Option
A-Award
Whitfield Roy A
Director
Director 8 000
Value: $455.2K
Sep 30, 2025
Buy
Stock Option
A-Award
Greer R Scott
Director
Director 8 000
Value: $455.2K
Sep 30, 2025
Buy
Stock Option
A-Award
Chess Robert
Director
Director 8 000
Value: $455.2K
Sep 30, 2025
Buy
Stock Option
A-Award
Brainard Diana
Director
Director 8 000
Value: $455.2K
Sep 30, 2025
Buy
Stock Option
A-Award
Ajer Jeffrey Robert
Director
Director 8 000
Value: $455.2K
Sep 30, 2025
Buy
Stock Option
A-Award
Ajer Jeffrey Robert
Director
Director 8 000
Value: $455.2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT NEKTAR THERAPEUTICS
Nektar Therapeutics
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, squamous cell carcinoma of the head and neck, and a...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE